TP53 and Huntington disease: Interestingly, we observed a stronger enrichment in SCD than in HD samples suggesting that HSPCs from SCD patients are more prone to inflammatory and P53 responses following electroporation and CRISPR-Cas9 treatment than HD cells (Figure 4D).